Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
Lingzhi(Ganoderma) is widely used in traditional Chinese medicine. Previous studies indicated
that Lingzhi was safe, well tolorated, and improved symptoms as an add-on therapy to levodopa
in early Parkinson's disease(PD) patients. Here the investigators design a multicenter,
randomized, double-blind, placebo-controlled, delayed-start trial to evaluate the effects of
Lingzhi on modifying disease progression in untreated PD patients.